Filtered By:
Condition: Heart Failure
Drug: Methamphetamine

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 5 results found since Jan 2013.

UCLA Nursing research on women and heart disease among key topics at nursing conference
New findings on the role gender plays in the diagnosis, treatment and prevention of heart disease will be among the research topics highlighted by faculty members and students from the UCLA School of Nursing at the annual Western Institute of Nursing Conference, which runs from April 11 to 13 in Anaheim, Calif.   At a special state-of-the-science panel on Saturday, April 13, UCLA professor Lynn V. Doering will present a review of gender differences in identification, treatment and outcomes for cardiovascular disease, with a focus on coronary atherosclerosis, heart failure and stroke. During the same panel, UCLA profes...
Source: UCLA Newsroom: Health Sciences - April 9, 2013 Category: Universities & Medical Training Source Type: news

Beta-blocker Use for Toxicity From “Bath Salts”
We appreciate the review of synthetic cathinones (“bath salts”) by Dr. Banks and colleagues (1). The long half-lives of these drugs are similar to methamphetamine, and persistent tachycardia and hypertension are problems that may lead to secondary injury such as acute coronary syndrome, heart failure, arterial dissection, and stroke (2–6). Indeed, the authors recognize this and write, “What is evident in these case reports is that tachycardia is more severe and more prevalent than hypertension; heart rates are commonly reported> 150 beats/min, whereas concomitant blood pressure (BP) might be normal or only mildly (systolic BP 
Source: The Journal of Emergency Medicine - November 18, 2014 Category: Emergency Medicine Authors: John R. Richards, Erik G. Laurin, Timothy E. Albertson Tags: Letter to the Editor Source Type: research

Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy
Conclusions MA-associated cardiomyopathy is characterized by severe heart failure and depressed cardiac function. The extent of myocardial fibrosis seems to predict the recoverability of LV function. Cessation of MA abuse is associated with improvement in cardiac function and symptoms, whereas continued MA abuse leads to ongoing heart failure and worse outcome. Graphical abstract
Source: JACC: Heart Failure - May 30, 2017 Category: Cardiology Source Type: research

Features and Outcomes of Methamphetamine Associated Pulmonary Arterial Hypertension.
CONCLUSIONS: Meth-APAH is a severe and progressive form of PAH with poor outcomes. Future studies should focus on mechanisms of disease and potential therapeutic considerations. PMID: 28934596 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - September 21, 2017 Category: Respiratory Medicine Authors: Zamanian RT, Hedlin H, Greuenwald P, Wilson DM, Segal JI, Jorden M, Kudelko K, Liu J, Hsi A, Rupp A, Sweatt AJ, Tuder R, Berry GJ, Rabinovitch M, Doyle RL, De Jesus Perez V, Kawut SM Tags: Am J Respir Crit Care Med Source Type: research

Methamphetamine ‐related cardiovascular diseases
ConclusionsAwareness is needed as cardiac complications are important causes of morbidity and mortality in patients with MA consumption. Drug abstinence is the mainstay of therapy, cardiac and other complications should be treated according to the respective guidelines. Incompliance to therapy and frequent relapses are the main challenges for successful treatment. Further research is required to improve the understanding of this rapidly increasing cardiomyopathy.
Source: ESC Heart Failure - January 16, 2020 Category: Cardiology Authors: Valentin Schwarzbach, Karsten Lenk, Ulrich Laufs Tags: Review Source Type: research